Analyst Ratings For bluebird bio (NASDAQ:BLUE)
Today, Maxim Group reiterated its Buy rating on bluebird bio (NASDAQ:BLUE) with a price target of $170.00.
There are 3 sell ratings, 5 hold ratings, 13 buy ratings on the stock.
The current consensus rating on bluebird bio (NASDAQ:BLUE) is Hold (Score: 2.48) with a consensus target price of $116.86 per share, a potential 11.14% downside.
Some recent analyst ratings include
- 10/9/2017-Maxim Group Reiterated Rating of Buy .
- 10/6/2017-Leerink Swann Reiterated Rating of Outperform.
- 10/6/2017-Goldman Sachs Group, Inc. (The) Reiterated Rating of Buy .
- 10/2/2017-Morgan Stanley was Downgraded by analysts at Morgan Stanley from a “Equal Weight ” rating to a ” Underweight” rating. They now have a $105.00 price target on the stock.
- 9/28/2017-Cantor Fitzgerald Reiterated Rating of Sell.
- 9/6/2017-Barclays PLC initiated coverage with a Overweight rating.
- 9/5/2017-Wells Fargo & Company Reiterated Rating of Outperform .
- On 10/2/2017 David Davidson, Insider, sold 4,000 with an average share price of $131.31 per share and the total transaction amounting to $525,240.00. View SEC Filing
- On 9/14/2017 John Maraganore, Director, sold 18,868 with an average share price of $131.21 per share and the total transaction amounting to $2,475,670.28. View SEC Filing
- On 9/12/2017 Mark Vachon, Director, sold 6,000 with an average share price of $126.82 per share and the total transaction amounting to $760,920.00. View SEC Filing
- On 9/11/2017 Jeffrey T Walsh, Insider, sold 4,900 with an average share price of $125.73 per share and the total transaction amounting to $616,077.00. View SEC Filing
- On 9/1/2017 Nick Leschly, Insider, sold 46,833 with an average share price of $122.27 per share and the total transaction amounting to $5,726,270.91. View SEC Filing
- On 8/31/2017 Daniel Lynch, Director, sold 500 with an average share price of $120.00 per share and the total transaction amounting to $60,000.00. View SEC Filing
- On 8/31/2017 Jeffrey T Walsh, Insider, sold 12,000 with an average share price of $125.01 per share and the total transaction amounting to $1,500,120.00. View SEC Filing
Recent Trading Activity for bluebird bio (NASDAQ:BLUE)
Shares of bluebird bio closed the previous trading session at with shares trading hands.